A carregar...
The Mechanisms of Cardiac Protection Using a Synthetic Agonist of Galanin Receptors during Chronic Administration of Doxorubicin
The use of the anticancer drug doxorubicin (Dox) is limited by its cardiotoxic effect. The aim of this work was to study the effect of a new synthetic agonist of the galanin receptor GalR1-3 [βAla14, His15]-galanine (2–15) (G) on the metabolism, antioxidant enzyme activity, and cardiac function in r...
Na minha lista:
| Publicado no: | Acta Naturae |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
A.I. Gordeyev
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7245963/ https://ncbi.nlm.nih.gov/pubmed/32477603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.32607/actanaturae.10945 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|